Cleared Traditional

K223306 - SPRINT Peripheral Nerve Stimulation (PNS) System (FDA 510(k) Clearance)

Jan 2023
Decision
90d
Days
Class 2
Risk

K223306 is an FDA 510(k) clearance for the SPRINT Peripheral Nerve Stimulation (PNS) System. This device is classified as a Stimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief (Class II - Special Controls, product code NHI).

Submitted by Spr Therapeutics, Inc. (Cleveland, US). The FDA issued a Cleared decision on January 25, 2023, 90 days after receiving the submission on October 27, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5890. Percutaneous Electrical Nerve Stimulator (pens) Is A Device Used For The Treatment Of Pain. Unlike The Classified Transcutaneous Electrical Nerve Stimulator That Apply An Electrical Current To Electrodes On A Patient's Skin To Deliver Stimulation, A Pens Uses Electrodes That Are Placed Percutaneously To Deliver Stimulation,.

Submission Details

510(k) Number K223306 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 27, 2022
Decision Date January 25, 2023
Days to Decision 90 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code NHI - Stimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5890
Definition Percutaneous Electrical Nerve Stimulator (pens) Is A Device Used For The Treatment Of Pain. Unlike The Classified Transcutaneous Electrical Nerve Stimulator That Apply An Electrical Current To Electrodes On A Patient's Skin To Deliver Stimulation, A Pens Uses Electrodes That Are Placed Percutaneously To Deliver Stimulation,